Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a research note published on Thursday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE AMPE opened at $0.00 on Thursday. The company has a market cap of $681.00, a P/E ratio of 0.00 and a beta of 3.66. The stock has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.01. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.47.

About Ampio Pharmaceuticals

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

See Also

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.